“Residual tissue from operating theatres is the future of biomedical research.”
The use of animal models in biomedical research is not only animal-unfriendly, but unfortunately also yields results that are difficult to translate to humans. That is why I have been dedicated for years to developing human-relevant models by using human tissues and cells in organ-on-a-chip models and organoids.
However, residual tissues are often difficult to obtain. And that is why I am so pleased with VitalTissue.
VitalTissue makes human residual tissue from hospitals available for scientific research. In doing so, they solve a challenging bottleneck in biomedical research. Residual tissues that would otherwise be lost now become available for innovative translational research.
And that is a huge step forward. Our research is accelerated and aligns better with human biology, while the use of animal testing decreases. And all of this is thanks to smooth service delivery. VitalTissue facilitates patient consent, ensures that the requested residual tissue becomes available, and arranges the transport.
I am curious about how colleagues view this. Would you like to make use of human residual tissue more often in your research?
Sue Gibbs – Professor of Skin and Mucosa Regenerative Medicine, Amsterdam UMC and ACTA
